Skip to content
lifestyle.recentlegalnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Transgene S.A.
Transgene to Present Preclinical Data on Novel Oncolytic Virus at SITC 2026 Supporting its Potential for Systemic Delivery
November 3, 2026
Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026
October 5, 2026
Transgene to Participate in Investor Access
October 1, 2026
Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field
September 24, 2026
Transgene & ProBioGen Expand Partnership with AGE1.CR.pIX Cell Line License
September 8, 2026
Transgene and Nec Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications
September 2, 2026
Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases
May 26, 2026
Transgene’s Combined General Meeting of May 22, 2026
May 22, 2026